Adductor canal block with different additives for total knee replacement surgery
Not Applicable
- Conditions
- Health Condition 1: M171- Unilateral primary osteoarthritisof knee
- Registration Number
- CTRI/2020/10/028528
- Lead Sponsor
- AIIMS RISHIKESH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA â??I, II
Patients undergoing primary unilateral total knee replacement
Exclusion Criteria
1.BMI > 35 kg/m2
2.Associated coagulation disorders
3.Infection at the site of injection
4.Severe cardiac,renal or hepatic dysfunction
5.Allergy to test drug
6.Any preâ?? existing sensory or motor impairement
7.Patient with cognitive impairement
8.Patient refusal to participate
9.Emergency surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare duration of analgesia (request for first rescue analgesia) after single-shot adductor canal block with ropivacaine and adjuvants (dexmedetomedine, fentanyl) in patients at rest undergoing primary unilateral total knee replacement with Numeric rating scaleTimepoint: At the first request for rescue analgesia in the post operative period during first 24 hours
- Secondary Outcome Measures
Name Time Method 1.To assess pain scores by numerical rating scale (NRS) post operatively <br/ ><br>2.To compare total rescue analgesia requirement in first 24hour after block <br/ ><br>3.To compare level of sensory block with either of adjuvants after ACB <br/ ><br>4.To compare any degree of motor blockade with any adjuvants in adductor canal block by modified bromage scale. <br/ ><br>5.To compare complications, if any ,while using either of the drugs <br/ ><br>Timepoint: Patient assessment for pain at 1,6,12,18 and 24 hour after block <br/ ><br>